Stay ahead in nonclinical drug development with the second volume in the CURRENT TOPICS IN NONCLINICAL DRUG DEVELOPMENT SERIES, expertly edited by Philip Bentley. This comprehensive volume delves into the critical issues and current topics in nonclinical drug development, covering strategies from compound characterization to drug registration.

Expert Insights into the Latest Advances

This authoritative guide features contributions from renowned experts in the field, who share their expertise on recent and rapid advances in technologies and associated changes in regulatory guidance. Explore the latest developments in:

• Artificial Intelligence (AI) technologies and their impact on toxicologic pathology
• Current approaches to carcinogenicity testing and predicting drug-drug interactions
• The current understanding of idiosyncratic drug reaction and assessing cardiovascular risks beyond QT interval
• The use of 3D cell cultures in toxicology and ADME
• Development of small molecule-antibody complexes and differentiating adverse from non-adverse findings in nonclinical studies

This valuable resource is designed to aid:

• Toxicologists, toxicologic pathologists, consultants, regulators, study directors, and nonclinical scientists dealing with day-to-day issues encountered in drug development
• Academicians and graduate students pursuing research related to nonclinical drug development

By providing comprehensive guidance on formulating strategies for resolving issues in drug development, CURRENT TOPICS IN NONCLINICAL DRUG DEVELOPMENT: VOLUME 2 serves as an indispensable reference for professionals and researchers in the field.

Details:

• Publisher: CRC Press
• Publication Date: November 9, 2023
• Language: English
• ISBN: 9780367466688, 9781000961126